These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 6784197)

  • 21. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
    De Gregorio G; Armeli G; Restivo S; Francolino A
    Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases].
    Eichhorn O
    Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281
    [No Abstract]   [Full Text] [Related]  

  • 25. [Controlled clinical study on the activity and tolerance of Trivastan].
    Nicrosini F; Pasotti C
    Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of Redergam (Latergal) in vascular diseases.
    Kovács E
    Ther Hung; 1986; 34(4):238-42. PubMed ID: 3449979
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cyclospasmol 400 in cerebral circulation insufficiency].
    Warot P
    Lille Med; 1973; 18(7):842-4. PubMed ID: 4603446
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
    Ishchenko MM; Shkrobot SI
    Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical use of a new vasoactive drug : nicergoline].
    Mellini M
    Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases].
    Sinforiani E; Trucco M; Pacchetti C; Gualtieri S
    Minerva Med; 1986 Jan; 77(1-2):51-7. PubMed ID: 3511406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
    Pöthig D; Sauer I; Hansen H; Weidnitzer M
    Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases].
    Montanini R; Gaspari G
    Minerva Cardioangiol; 1969 Dec; 17(12):1096-102. PubMed ID: 5373481
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of the effectiveness of treatment with diverse doses of cinnarizine of patients with circulatory encephalopathy].
    Shtok VN; Fedorova NV; Pavlov IuV; Traĭtel' BIa
    Klin Med (Mosk); 1989 Sep; 67(9):55-8. PubMed ID: 2586043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current trends in drug therapy of cerebral ictus].
    Foglia M; Repaci G; Mazzei V; Carulli E; Mapelli A
    Arch Sci Med (Torino); 1978; 135(3):417-22. PubMed ID: 708093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of piracetam on cerebral hemodynamics in patients with arteriosclerosis and dyscirculatory encephalopathy].
    Vesel'skiĭ ISh; Voroniuk MI
    Klin Med (Mosk); 1986 Jun; 64(6):41-4. PubMed ID: 3747435
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
    Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M; Jacquy J; Noel G
    Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dihydroergotoxine mesylate in chronic cerebrovascular insufficiency: spectral EEG analysis and neuropsychological correlates].
    Moglia A; Bono G; Sinforiani E; Alfonsi E; Zandrini C; Pistarini C; Arrigo A; Franch F
    Farmaco Prat; 1983 Feb; 38(2):97-102. PubMed ID: 6832350
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
    Piguet PV; Zoufal Z
    Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of cerebrovascular processes and their reactions to pharmacotherapy by means of ultrasonic methods.
    Klein K; Klein M; Klein P
    Z Alternsforsch; 1985; 40(6):369-74. PubMed ID: 2934900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.